Milestone Pharmaceuticals Inc.
MIST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$41,519 | -$59,685 | -$58,388 | -$42,853 |
| Dep. & Amort. | $105 | $92 | $89 | $93 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,776 | $9,534 | $9,048 | $7,279 |
| Change in WC | $3,656 | $1,243 | -$3,262 | $2,257 |
| Other Non-Cash | $3,134 | $2,392 | $44 | $0 |
| Operating Cash Flow | -$28,848 | -$46,424 | -$52,469 | -$33,224 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$33 | -$112 | -$272 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$113,554 | -$137,132 | -$85,852 | -$15,000 |
| Inv. Sales/Matur. | $121,870 | $142,000 | $29,000 | $85,000 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $8,283 | $4,756 | -$57,124 | $70,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $50,000 | $0 | $0 |
| Stock Issued | $27,258 | $0 | $2,630 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,861 | -$2,208 | $458 | $5,055 |
| Financing Cash Flow | $32,119 | $47,792 | $3,088 | $5,055 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $11,554 | $6,124 | -$106,505 | $41,831 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $13,760 | $7,636 | $114,141 | $72,310 |
| End Cash | $25,314 | $13,760 | $7,636 | $114,141 |
| Free Cash Flow | -$28,881 | -$46,536 | -$52,741 | -$33,224 |